GLP-1 Receptor Agonist: Weight Loss Clinical Evidence
GLP-1 Clinical Relevance #51Moderate Clinical Relevance Relevant context for GLP-1 prescribers; interpret with care. ⚕ GLP-1 News | CED Clinic Clinical CommentaryObservational StudyWeight Loss MaintenanceSemaglutideFamily…
GLP-1 Weight Loss Medicine: Clinical Evidence & Access
GLP-1 Clinical Relevance #42Contextual Information Background context; limited direct clinical applicability. ⚕ GLP-1 News | CED Clinic Clinical CommentaryService Model AnalysisObesity ManagementGLP-1 Receptor AgonistPrimary…
Topical Cannabis for AIMSS: Clinical Trial Evidence
Clinical Takeaway Topical cannabis balms were tolerable and feasible for women with aromatase inhibitor-related joint pain and stiffness, which affects about two-thirds of women taking these breast cancer medications. This approach could help improve…
GLP-1 Receptor Agonist Randomized Trials: Clinical Evidence
GLP-1 Clinical Relevance #35Contextual Information Background context; limited direct clinical applicability. ⚕ GLP-1 News | CED Clinic Clinical NewsObservational DataObesity TreatmentGLP-1 Receptor AgonistPrimary CareAdults with…
GLP-1 Receptor Agonist Users: The Biggest Clinical Mistake
GLP-1 Clinical Relevance #41Contextual Information Background context; limited direct clinical applicability. ⚕ GLP-1 News | CED Clinic NewsObservationalObesityGLP-1 Receptor AgonistPrimary CareAdults with ObesityWeight…
Trulieve to Open Medical Cannabis Dispensary in Lutz, Florida – PR Newswire
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic AccessFloridaMedical CannabisPatient…
Push to repeal New York medical cannabis tax amid ‘crisis’ claims – MJBizDaily
✦ New CED Clinical Relevance #55 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyIndustryPain Why This Matters New York’s proposed tax repeal is clinically relevant because the current…
Topical Cannabis for AIMSS: Cannabinoid Clinical Trials
Clinical Takeaway Topical cannabis balms were tested in a randomized trial for postmenopausal breast cancer patients experiencing joint pain and stiffness caused by aromatase inhibitor therapy. The study evaluated whether this approach was practical and…